News
09-09-2020, 04:39 PM
Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington University Department of Dermatology.
More... (https://www.news-medical.net/news/20200909/Spironolactone-may-be-safe-to-treat-female-pattern-hair-loss-in-breast-cancer-survivors.aspx)
More... (https://www.news-medical.net/news/20200909/Spironolactone-may-be-safe-to-treat-female-pattern-hair-loss-in-breast-cancer-survivors.aspx)